QIAGEN announces broad agreement with Astellas Pharma to develop companion diagnostics
First two programs aim to create tests to aid in cancer treatment with Astellas compounds under development
30-Oct-2014 -
QIAGEN N.V. announced a master collaboration agreement with Astellas Pharma Inc. to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases. The scope of the agreement is not restricted to certain sample types, platforms, indications or ...
companion diagnostics
oncology
Qiagen